Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
08:30am, Wednesday, 03'rd Jun 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that cert
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
04:00pm, Monday, 18'th May 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company w
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
10:19am, Monday, 18'th May 2026
Maravai LifeSciences Holdings, Inc. is upgraded to Buy, driven by operational restructuring, improved guidance, and sector recovery. MRVI raised 2026 revenue guidance to $205–$215M and adjusted EBIT
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
11:57am, Sunday, 10'th May 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Maravai LifeSciences Q1 Earnings Call Highlights
04:10pm, Friday, 08'th May 2026
Maravai LifeSciences NASDAQ: MRVI reported first-quarter fiscal 2026 results that management said marked a “strong start to 2026,” driven by growth at its TriLink segment, steady contribution from
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
06:55pm, Thursday, 07'th May 2026
Maravai LifeSciences Holdings, Inc. (MRVI) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to a loss of $0.08 per
Maravai LifeSciences Reports First Quarter 2026 Financial Results
04:01pm, Thursday, 07'th May 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy
01:01pm, Wednesday, 06'th May 2026
Maravai LifeSciences (MRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates
09:30am, Thursday, 30'th Apr 2026
Baxter International (BAX) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.55 per share a year ago.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Rating of “Hold” from Brokerages
02:38am, Monday, 06'th Apr 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com repor
Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)
01:09am, Thursday, 02'nd Apr 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) was the target of some unusual options trading activity on Wednesday. Traders bought 1,002 put options on the stock. This represent
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript
05:08pm, Thursday, 26'th Feb 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates
08:25pm, Wednesday, 25'th Feb 2026
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year a
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
04:01pm, Wednesday, 25'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
Maravai LifeSciences (MRVI) to Release Quarterly Earnings on Wednesday
05:48am, Monday, 23'rd Feb 2026
Maravai LifeSciences (NASDAQ: MRVI - Get Free Report) will likely be issuing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings o
